Heart-Brain Interactions

 Book
Print on Demand | Lieferzeit:3-5 Tage I

122,47 €*

Alle Preise inkl. MwSt. | zzgl. Versand
ISBN-13:
9783642766541
Einband:
Book
Erscheinungsdatum:
23.12.2011
Seiten:
248
Autor:
Giuseppe Di Pasquale
Gewicht:
380 g
Format:
235x155x13 mm
Sprache:
Englisch
Beschreibung:

This book describes the interactions between the heart and the brain with emphasis on cerebral ischemia, which is mainly related to the different forms of arteriosclerotic heart and vessel diseases.
I Cardiovascular Consequences of Cerebral Damage.- The Visceral Nervous System as a Link Between the Heart and the Brain: An Approach Employing Spectral Analysis of R-R and Systolic Arterial Pressure Variabilities.- Electrocardiographic Changes Following Acute Ischemic or Hemorrhagic Stroke.- Cardiac Arrhythmias Following Acute Brain Injuries.- Clinical Evidence of Myocardial Damage in Patients with Acute Subarachnoid Hemorrhage.- Pathologic Evidence of Myocardial Damage Following Acute Brain Injuries.- Prevention of Myocardial Damage Following Acute Brain Injuries by Beta-Blockade.- II Cardiogenic Cerebral Ischemia: Diagnostic and Therapeutic Aspects.- Cardiogenic Focal Cerebral Ischemia in Patients Under 45 Years.- Diagnostic-Therapeutic Protocol of Syncope.- Cardioembolic Stroke: Prevalence, Diagnosis, and Treatment.- Thromboembolism in Nonrheumatic Atrial Fibrillation: What Have We Learned?.- Usefulness of Transthoracic, Transesophageal, and Contrast Ecocardiography in Patients with Suspected Cardioembolic Stroke.- Two-Dimensional Echocardiography in Young Adults with Cerebral Ischemia: Emerging Issues.- III Cerebrovascular and Coronary Artery Disease.- 1 Risk Factors.- Arterial Hypertension and Risk of Stroke and Myocardial Infarction.- Hyperlipidemia and Risk of Stroke.- 2 Detection of Association.- Noninvasive Investigation for the Detection of Asymptomatic Ischemic Heart Disease in Cerebrovascular Patients.- Multifocal Atherosclerotic Noninvasive Findings in Patients with Coronary Artery Disease.- 3 Medical Treatment.- Pharmacological Approaches to the Regression of Atherosclerotic Lesions of the Carotid or Coronary Arteries.- Antiplatelet Therapy and Prevention of Myocardial Ischemia.- Antiplatelet Therapy in Stroke Prevention.- Heparin in the Treatment of Cerebral and Myocardial Ischemia.- Thrombolytic Therapy in Acute Myocardial Infarction.- Thrombolytic Treatment of Patients with Acute Ischemic Stroke.- Management of Acute Ischemic Stroke.- 4 Surgical Treatment.- Carotid Endarterectomy: Wider Indications or Better Selection?.- Surgical Strategy in Patients with Associated Carotid and Coronary Artery Lesions: Staged or Combined Operations?.
In the last decade there has been a growing interest in the study of the interactions between the heart and the brain, especially in the field of cerebral ischemia. The interactions between cardiovascular and cerebrovascular diseases are of relevance not only for research investigation, but also for clinical implications in the daily clinical practice. i.e. A wealth of information has been gathered particularly on three topics, cardiovascular consequences of cerebral injuries, cardioembolic stroke, and association of carotid and coronary artery disease. The available information, however, is still sparse and fragmentary mainly because of the lack of commun ication between neurologists and cardiologists. With the aim of improving communication between several disciplines and technologies, we started to organize since 1987 in Bologna, Italy, an international Symposium on heart brain interactions to be held every 3 years. Our intention was to gather prominent clinicians and researchers from outstanding cardiologic and neuro logic institutions actively involved in the study of heart-brain interactions. The ambitious goal has been to fit different pieces of information like in a puzzle. This book originates from the contributions presented at the 2nd Sympo sium which was held in Bologna on November 30-December 1, 1990. The book is subdivided into three sections: I cardiovascular consequences of cerebral damage, II cardiogenic cerebral ischemia, III cerebrovascular and coronary artery disease.